• Bortezomib Beyond Cancer: A Proteasome-to-Thymus Lens

  2026-08-28

  Bortezomib (PS-341) is best known as a reversible 20S proteasome inhibitor in oncology, but new thymus-regeneration research broadens the strategic questions translational scientists should ask. This article connects proteasome inhibition, FOXN1 biology, ER stress, autophagy, and assay design while distinguishing established evidence from forward-looking hypotheses.

• Deferasirox Fe3+ chelate in Cell Assays

  2026-08-28

  Learn how Deferasirox Fe3+ chelate, SKU A3355, can help researchers control iron-related variables in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects formulation, solvent handling, lysosomal biology, and vendor selection to practical experimental decisions.

• VER 155008: HSP 70 Inhibitor Workflow

  2026-08-27

  Build a practical Hsp70 inhibition workflow that connects ATPase-pocket biochemistry with apoptosis, cancer cell proliferation inhibition, and proteomic response mapping. VER 155008 is especially useful for separating Hsp70-family dependence from HSP90-driven client-protein biology in cancer research.

• Temozolomide in ATRX-Deficient Glioma Research

  2026-08-27

  A translational perspective on using Temozolomide to connect DNA damage biology, ATRX status, resistance mechanisms, and more informative glioma model design.

• Amyloid β-Peptide (1-42): Assay Workflows

  2026-08-26

  Build reproducible Aβ42 peptide workflows for aggregation imaging, neuronal toxicity, and ion-channel studies. This guide connects fresh peptide handling with ratiometric fibril detection and practical troubleshooting for Alzheimer’s disease research.

• X-press Tag Peptide for RHEB Assays

  2026-08-26

  Use the X-press Tag Peptide as a three-in-one handle for affinity capture, Anti-Xpress antibody detection, and controlled enterokinase release. This workflow is especially useful for producing and comparing RHEB variants when investigating the UBE2F–SAG–RHEB–mTORC1 signaling axis.

• Pregnenolone Carbonitrile Beyond Canonical PXR

  2026-08-25

  Pregnenolone Carbonitrile is more than a rodent PXR agonist for xenobiotic metabolism research. This thought-leadership analysis examines its tissue-specific CYP response, antifibrotic potential, formulation considerations, and translational value as a mechanistic probe rather than a simple induction control.

• ATRX-Deficient Glioma and RTK Inhibitor Sensitivity

  2026-08-25

  Pladevall-Morera et al. show that ATRX-deficient high-grade glioma cells are more vulnerable to multi-targeted RTK and PDGFR inhibitors than ATRX-proficient models. The study also reports pronounced toxicity when selected inhibitors are combined with Temozolomide, supporting ATRX status as a useful variable for glioma pharmacology and clinical-trial interpretation.

• Bestatin (Ubenimex): Aminopeptidase Assay Guide

  2026-08-24

  Bestatin (Ubenimex) is a selective aminopeptidase perturbation tool for connecting enzyme activity with cell phenotypes, multidrug resistance, and signaling responses. This guide converts its inhibition profile into practical workflows for aminopeptidase activity measurement, apoptosis assay design, cancer research, and plant chemical genetics.

• RIPA Lysis Buffer (Strong) for BBB Protein Studies

  2026-08-24

  Build reproducible lysates from astrocytes, brain endothelial cells, co-cultures, and animal tissues for pathway-focused protein analysis. This workflow shows how strong detergent chemistry supports Western blotting, ELISA, and carefully controlled immunoprecipitation while preserving practical options for troubleshooting.

• N-MYC–eIF4G1 Survival Axis in inv(16) AML

  2026-08-23

  Peramangalam et al. identify an N-MYC-driven survival program in inv(16) acute myeloid leukemia, centered on a previously unrecognized MYCN enhancer and the translation factor eIF4G1. The study connects disruption of CBFβ-SMMHC–RUNX1 signaling with MYCN repression and provides a mechanistic framework for investigating leukemia maintenance in cellular and patient-derived models.

• TTP, m6A, and Liver Fibrosis in Schistosomiasis

  2026-08-22

  The reference study identifies tristetraprolin as an anti-fibrotic regulator that promotes WTAP transcription through SMAD2/3 and alters TGF-β1 mRNA stability through m6A modification. Its integrated genetic, transcriptomic, epitranscriptomic, and proteomic design provides a framework for testing how RNA methylation controls hepatic stellate cell activation during Schistosoma japonicum infection.

• LY2886721 Workflow for BACE1 Research

  2026-08-22

  LY2886721 supports controlled BACE1 enzyme inhibition across cellular, neuronal, biomarker, and oral in vivo workflows. Its strongest use-case is dose-calibrated amyloid beta reduction paired with synaptic-function monitoring, helping researchers distinguish pathway engagement from excessive physiological disruption.

• Live-Dead Cell Staining Kit I for Ferroptosis

  2026-08-21

  Discover how the Live-Dead Cell Staining Kit I (Calcein AM/PI) can strengthen mammalian cell viability assay design in ferroptosis research. This article focuses on interpreting membrane integrity, esterase activity, and mechanistic evidence without mistaking a viability endpoint for proof of cell-death identity.

• Pemetrexed: From Folate Stress to Assay Design

  2026-08-20

  Pemetrexed is more than a broad antifolate: it is a practical probe for separating nucleotide stress from DNA-repair vulnerability. This guide integrates pemetrexed disodium chemistry, malignant mesothelioma evidence, and assay-design decisions for translational cancer research.

8027 records 1/536 page Next 12345 下5页 Last page